Kumar, A., Franek, E., Wise, J., Niemeyer, M., Mersebach, H., & Simó, R. (2016). Efficacy and Safety of Once-Daily Insulin Degludec/Insulin Aspart versus Insulin Glargine (U100) for 52 Weeks in Insulin-Naïve Patients with Type 2 Diabetes: A Randomized Controlled Trial. PLoS One.
Chicago Stili AlıntıKumar, Ajay, Edward Franek, Jonathan Wise, Marcus Niemeyer, Henriette Mersebach, ve Rafael Simó. "Efficacy and Safety of Once-Daily Insulin Degludec/Insulin Aspart Versus Insulin Glargine (U100) for 52 Weeks in Insulin-Naïve Patients With Type 2 Diabetes: A Randomized Controlled Trial." PLoS One 2016.
MLA AlıntıKumar, Ajay, et al. "Efficacy and Safety of Once-Daily Insulin Degludec/Insulin Aspart Versus Insulin Glargine (U100) for 52 Weeks in Insulin-Naïve Patients With Type 2 Diabetes: A Randomized Controlled Trial." PLoS One 2016.